Schillinger Robert J, Mwakamui Simutanyi, Mulenga Chola, Tembo Mizinga, Hodges Phoebe, Besa Ellen, Chandwe Kanta, Owino Victor O, Edwards Christine A, Kelly Paul, Morrison Douglas J
Scottish Universities Environmental Research Centre, University of Glasgow, East Kilbride, United Kingdom.
School of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow, United Kingdom.
Front Med (Lausanne). 2022 Jul 29;9:904339. doi: 10.3389/fmed.2022.904339. eCollection 2022.
Environmental enteropathy (EE) is a subclinical disorder highly prevalent in tropical and disadvantaged populations and is thought to play a role in growth faltering in children, poor responses to oral vaccines, and micronutrient deficiencies. This study aims to evaluate the potential of a non-invasive breath test based on stable isotopes for evaluation of impaired digestion and absorption of sucrose in EE.
We optimized a C-sucrose breath test (C-SBT) in 19 young adults in Glasgow, United Kingdom. In a further experiment (in 18 adults) we validated the C-SBT using Reducose, an intestinal glucosidase inhibitor. We then compared the C-SBT to intestinal mucosal morphometry, immunostaining for sucrose-isomaltase (SI) expression, and SI activity in 24 Zambian adults with EE.
Fully labeled sucrose (0.3 mg/kg) provided clear breath enrichment signals over 2-3 h in both British and Zambian adults, more than fivefold higher than naturally enriched sucrose. Reducose dramatically impaired C-sucrose digestion, reducing 4 h CO breath recovery by > 50%. Duodenal biopsies in Zambian adults confirmed the presence of EE, and SI immunostaining was present in 16/24 adults. The kinetics of CO evolution were consistently faster in participants with detectable SI immunostaining. Although sucrase activity was strongly correlated with villus height ( = 0.72; < 0.05) after adjustment for age, sex and body mass index, there were no correlations between C-SBT and villus height or measured sucrase activity in pinch biopsies.
A C-SBT was developed which was easy to perform, generated clear enrichment of CO in breath samples, and clearly reports sucrase activity. Further work is needed to validate it and understand its applications in evaluating EE.
环境肠病(EE)是一种在热带地区和弱势群体中高度流行的亚临床疾病,被认为在儿童生长发育迟缓、口服疫苗反应不佳以及微量营养素缺乏中起作用。本研究旨在评估基于稳定同位素的非侵入性呼气试验在评估EE患者蔗糖消化吸收受损方面的潜力。
我们在英国格拉斯哥的19名年轻成年人中优化了¹³C-蔗糖呼气试验(C-SBT)。在进一步的实验(18名成年人)中,我们使用肠道葡萄糖苷酶抑制剂Reducose验证了C-SBT。然后,我们将C-SBT与24名患有EE的赞比亚成年人的肠黏膜形态学、蔗糖异麦芽糖酶(SI)表达的免疫染色以及SI活性进行了比较。
完全标记的蔗糖(0.3 mg/kg)在英国和赞比亚成年人中均在2 - 3小时内提供了清晰的呼气富集信号,比自然富集的蔗糖高五倍以上。Reducose显著损害了¹³C-蔗糖的消化,使4小时的¹³CO呼气回收率降低了>50%。赞比亚成年人的十二指肠活检证实了EE的存在,16/24名成年人存在SI免疫染色。在可检测到SI免疫染色的参与者中,¹³CO释放的动力学始终更快。尽管在调整年龄、性别和体重指数后,蔗糖酶活性与绒毛高度密切相关(r = 0.72;P < 0.05),但C-SBT与绒毛高度或捏取活检中测得的蔗糖酶活性之间没有相关性。
开发了一种C-SBT,其操作简便,能在呼气样本中产生清晰的¹³CO富集,并能清楚地反映蔗糖酶活性。需要进一步开展工作以验证其有效性并了解其在评估EE中的应用。